Laboratoire d’hématologie
Claude Preudhomme has not added Biography.
If you are Claude Preudhomme and would like to personalize this page please email our Author Liaison for assistance.
Unlike AML1, CBFbeta gene is not deregulated by point mutations in acute myeloid leukemia and in myelodysplastic syndromes.
Blood May, 2002 | Pubmed ID: 11986246
M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: a report of 59 cases by the Groupe Français d'Hématologie Cellulaire (GFHC) and the Groupe Français de Cytogénétique Hématologique (GFCH).
Blood Feb, 2003 | Pubmed ID: 12393381
Mesenchymal cells generated from patients with myelodysplastic syndromes are devoid of chromosomal clonal markers and support short- and long-term hematopoiesis in vitro.
Oncogene Apr, 2005 | Pubmed ID: 15735749
Involvement of a common progenitor cell in core binding factor acute myeloid leukaemia associated with mastocytosis.
Leukemia research Nov, 2012 | Pubmed ID: 22871474
Linezolid induces ring sideroblasts.
Haematologica Nov, 2013 | Pubmed ID: 24186315
NUP214-ABL1 fusion defines a rare subtype of B-cell precursor acute lymphoblastic leukemia that could benefit from tyrosine kinase inhibitors.
Haematologica Apr, 2016 | Pubmed ID: 26681761
Acquisition of genomic events leading to lymphoblastic transformation in a rare case of myeloproliferative neoplasm with BCR-JAK2 fusion transcript.
European journal of haematology Oct, 2016 | Pubmed ID: 26935241
Comprehensive mutational profiling of core binding factor acute myeloid leukemia.
Blood 05, 2016 | Pubmed ID: 26980726
Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study.
The Lancet. Haematology Apr, 2016 | Pubmed ID: 27063977
Tetraspanin CD81 is an adverse prognostic marker in acute myeloid leukemia.
Oncotarget 09, 2016 | Pubmed ID: 27566555
Myelodysplastic syndromes and acute leukemia with genetic predispositions: a new challenge for hematologists.
Expert review of hematology Dec, 2016 | Pubmed ID: 27819178
High-throughput sequencing in acute lymphoblastic leukemia: Follow-up of minimal residual disease and emergence of new clones.
Leukemia research Feb, 2017 | Pubmed ID: 27930944
Detection of a new heterozygous germline ETV6 mutation in a case with hyperdiploid acute lymphoblastic leukemia.
European journal of haematology Jan, 2018 | Pubmed ID: 29034503
SNP-array lesions in core binding factor acute myeloid leukemia.
Oncotarget Jan, 2018 | Pubmed ID: 29464086
Thomas Boyer1,2,
Fanny Gonzales2,3,
Adriana Plesa4,
Pauline Peyrouze2,
Adeline Barthelemy2,
Soizic Guihard2,
Bruno Quesnel2,5,
Christophe Roumier1,2,
Claude Preudhomme1,2,
Meyling Cheok2
1Laboratoire d’hématologie, CHU Lille,
2, Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - JPArc - Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer,
3Service d’hématologie pédiatrique, hôpital Jeanne de Flandre, CHU Lille,
4, Laboratoire d’hématologie CH Lyon Sud,
5Service des Maladies du Sang, hôpital Claude Huriez, CHU Lille
JoVEについて
Copyright © 2023 MyJoVE Corporation. All rights reserved